We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.17%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KWR icon
476
Quaker Houghton
KWR
$2.91B
$203M 0.03%
1,359,780
+93,539
+7% +$14.5M
MTDR icon
477
Matador Resources
MTDR
$6.5B
$202M 0.03%
4,326,071
+135,179
+3% +$7.34M
MU icon
478
Micron Technology
MU
$1.03T
$201M 0.03%
3,642,323
-282,718
-7% -$19.2M
CL icon
479
Colgate-Palmolive
CL
$73.6B
$201M 0.03%
2,506,737
+234,113
+10% +$18.3M
COUP
480
DELISTED
Coupa Software Incorporated
COUP
$201M 0.03%
3,511,814
-1,630,260
-32% -$126M
MO icon
481
Altria Group
MO
$107B
$200M 0.03%
4,791,365
-1,968,139
-29% -$102M
WK icon
482
Workiva
WK
$3.7B
$199M 0.03%
3,022,057
+564,500
+23% +$47M
SCHL icon
483
Scholastic
SCHL
$792M
$198M 0.03%
5,496,106
-255,147
-4% -$9.42M
WDC icon
484
Western Digital
WDC
$157B
$197M 0.02%
5,827,019
+5,234,357
+883% +$210M
FBK icon
485
FB Financial Corp
FBK
$3.1B
$194M 0.02%
4,937,234
+6,639
+0.1% +$267K
OGS icon
486
ONE Gas
OGS
$5.05B
$194M 0.02%
2,383,887
-648,739
-21% -$55.5M
BDXB
487
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
$193M 0.02%
3,888,470
+583,956
+18% +$29.9M
HSY icon
488
Hershey
HSY
$37B
$193M 0.02%
895,994
-72,592
-7% -$15.8M
SSNC icon
489
SS&C Technologies
SSNC
$18.8B
$192M 0.02%
3,312,406
+24,331
+0.7% +$1.56M
NFG icon
490
National Fuel Gas
NFG
$7.77B
$192M 0.02%
2,907,176
-1,150,092
-28% -$80.7M
DOCU
491
DocuSign
DOCU
$11.1B
$191M 0.02%
3,335,634
-6,523,057
-66% -$528M
LOB icon
492
Live Oak Bancshares
LOB
$1.98B
$191M 0.02%
5,640,107
+223,059
+4% +$9.22M
HCP
493
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$190M 0.02%
6,460,529
+1,776,699
+38% +$71.7M
OLPX
494
DELISTED
Olaplex Holdings
OLPX
$190M 0.02%
13,465,001
+2,193,104
+19% +$32.4M
ESE icon
495
ESCO Technologies
ESE
$7.78B
$188M 0.02%
2,747,370
+91,085
+3% +$5.95M
PRGO icon
496
Perrigo
PRGO
$1.76B
$187M 0.02%
4,597,277
-3,820,473
-45% -$142M
UFPI icon
497
UFP Industries
UFPI
$5.06B
$186M 0.02%
2,728,889
-16,634
-0.6% -$1.25M
GLOB icon
498
Globant
GLOB
$1.67B
$186M 0.02%
1,067,477
+150,994
+16% +$30.7M
CRSP icon
499
CRISPR Therapeutics
CRSP
$5.22B
$183M 0.02%
3,014,551
+1,848,437
+159% +$109M
WABC icon
500
Westamerica Bancorp
WABC
$1.38B
$183M 0.02%
3,285,552
-342,451
-9% -$20.1M

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.